At its October 2002 meeting, the board decided that if a medicinal product is to be eligible for purchase using Global Fund grants, it must meet various requirements. One of these is that if it is a “single- or limited-source product,” it must (a) have been found to be acceptable by the WHO-initiated UN Pilot Procurement Quality and Sourcing Project,…
![Quality Assurance of Limited Source Pharmaceutical Products](https://aidspan.org/wp-content/uploads/2023/01/WhatsApp-Image-2023-01-16-at-10.07.45-AM-1024x576.jpeg)